LESLEY N GLOVER

Allopathic & Osteopathic Physicians|Family Medicine WELLINGTON, FL NPI 1730140211

General Payments — all program years on this page

$8,109.81

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 475
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $752.70 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $743.8840
Education $8.821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,612.95100
2019 $1,614.1298
2020 $1,558.3695
2021 $991.4060
2022 $720.6438
2023 $859.6443
2024 $752.7041

Records — PY2024 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086202842 Bayer Healthcare Pharmaceuticals Inc. $20.86 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096626523 Novo Nordisk Inc $23.71 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096686676 Novo Nordisk Inc $3.75 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096793859 Novo Nordisk Inc $24.37 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096816010 Novo Nordisk Inc $13.46 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096953844 Novo Nordisk Inc $8.82 04/30/2024 Education Undisputed 01/23/2026 View at CMS
1097082443 Novo Nordisk Inc $16.73 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097165868 Novo Nordisk Inc $14.81 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097576141 Novo Nordisk Inc $23.91 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097736865 Novo Nordisk Inc $2.66 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097778247 Novo Nordisk Inc $18.80 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805116 ABBVIE INC. $16.56 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805118 ABBVIE INC. $13.15 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805120 ABBVIE INC. $23.55 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805122 ABBVIE INC. $29.89 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104427219 AstraZeneca Pharmaceuticals LP $18.64 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104492982 AstraZeneca Pharmaceuticals LP $15.09 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104546946 AstraZeneca Pharmaceuticals LP $14.66 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104716035 AstraZeneca Pharmaceuticals LP $15.82 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104733153 AstraZeneca Pharmaceuticals LP $16.30 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105256244 AstraZeneca Pharmaceuticals LP $15.49 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105649296 AstraZeneca Pharmaceuticals LP $16.46 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105783074 AstraZeneca Pharmaceuticals LP $23.81 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105799014 AstraZeneca Pharmaceuticals LP $18.17 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105857618 AstraZeneca Pharmaceuticals LP $15.88 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105862650 AstraZeneca Pharmaceuticals LP $15.33 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118130125 Boehringer Ingelheim Pharmaceuticals, Inc. $14.64 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118130127 Boehringer Ingelheim Pharmaceuticals, Inc. $17.52 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131095347 PFIZER INC. $21.32 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131100066 PFIZER INC. $19.75 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131115738 PFIZER INC. $23.69 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131367614 PFIZER INC. $27.15 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131615504 PFIZER INC. $18.44 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131744148 PFIZER INC. $25.33 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131870742 PFIZER INC. $19.09 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131975511 PFIZER INC. $22.76 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132086506 PFIZER INC. $16.76 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132126000 PFIZER INC. $22.21 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135150596 Lilly USA, LLC $13.07 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145919169 Lundbeck LLC $26.47 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148298812 Axsome Therapeutics, Inc. $23.82 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.